Why the study?
Epithelioid angiosarcoma is an extremely rare, highly aggressive cardiac subtype with poorly understood epidemiology and pathogenesis, leaving effective diagnostic and treatment modalities limited.
Surgical resection of a rare, life-threatening primary cardiac epithelioid angiosarcoma can result in sustained remission and favorable clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Supports surgical resection feasibility in rare cardiac epithelioid angiosarcoma; leaves open need for larger studies on durability and management.
Kyaw et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: